Stock BCART BIOCARTIS GROUP NV
Add to a list
To use this feature you must be a member
Log inSign up

Company Biocartis Group NV

Equities

BCART

BE0974281132

Medical Equipment, Supplies & Distribution

Market Closed - Euronext Bruxelles
Other stock markets
 11:35:06 2023-09-22 am EDT 		5-day change 1st Jan Change
0.29 EUR +1.05% Intraday chart for Biocartis Group NV -.--% -.--%
2023 Biocartis Group NV Presents Four Abstracts Showing Excellent Data for Idylla at European Society of Molecular Oncology Congress CI
2023 Biocartis, APIS Assay Technologies to Commercialize Estrogen Receptor-positive Mutations Kit MT

Business Summary

Biocartis Group NV specializes in the development of molecular diagnostic systems. Especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.

Net sales by source of income are mainly distributed between products sales (78.3%) and sale of collaboration services (19.3%; especially research and development services).

Number of employees: 526

Sales per Business

EUR in Million2021Weight2022Weight Delta
Cartridge
62.4 %
32 65.5 % 36 62.4 % +13.43%
Research & Development Services
18.3 %
6 12.2 % 11 18.3 % +79.02%
Idylla System Rental
8.7 %
4 7.9 % 5 8.7 % +30.60%
Idylla System
7.3 %
5 10.5 % 4 7.3 % -17.19%
Idylla System Service
2.4 %
2 3.6 % 1 2.4 % -20.40%
Milestone
0.8 %
- - 0 0.8 % -
License Fees
0.2 %
0 0.4 % 0 0.2 % -45.95%

Sales per region

EUR in Million2021Weight2022Weight Delta
Rest of the World
34.1 %
16 32.9 % 20 34.1 % +23.67%
United States
28.4 %
11 22.7 % 16 28.4 % +48.80%
Great Britain
9.6 %
8 16.4 % 6 9.6 % -30.68%
France
8.3 %
4 8.9 % 5 8.3 % +10.97%
Spain
7.8 %
3 7.2 % 4 7.8 % +29.32%
Germany
7.5 %
4 7.5 % 4 7.5 % +19.26%
China
3.3 %
1 3.1 % 2 3.3 % +26.43%
Belgium
1.0 %
1 1.3 % 1 1.0 % -5.83%

Managers

Managers TitleAgeSince
John Roger Moody CEO
 Chief Executive Officer 56 23-04-23
Herman Verrelst CHM
 Chairman 51 17-08-30
George Cardoza DFI
 Director of Finance/CFO 62 23-08-06
Piet Houwen COO
 Chief Operating Officer 57 -
Renate Degrave IRC
 Investor Relations Contact - 14-12-31
Susy Spruyt HRO
 Human Resources Officer 56 15-08-31

Members of the board

Members of the board TitleAgeSince
John Roger Moody CEO
 Chief Executive Officer 56 23-04-23
Christian Reinaudo BRD
 Director/Board Member 70 18-05-10
Luc Gijsens BRD
 Director/Board Member 71 18-05-10
Ann-Christine Sundell BRD
 Director/Board Member 60 18-05-10
Herman Verrelst CHM
 Chairman 51 17-08-30
Christine D. Kuslich BRD
 Director/Board Member 57 19-12-31
Bryan DeChairo BRD
 Director/Board Member 52 23-02-20

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 93,915,910 87,729,761 ( 93.41 %) 0 93.41 %

Shareholders

NameEquities%Valuation
Invesco Advisers, Inc.
9.842 %
9,243,176 9.842 % 3 M €
SFPI-FPIM (Private Equity)
7.149 %
6,713,856 7.149 % 2 M €
Heights Capital Management, Inc.
4.901 %
4,602,990 4.901 % 1 M €
JOHNSON & JOHNSON
4.089 %
3,840,474 4.089 % 1 M €
CAPFI DELEN Asset Management NV
0.6409 %
601,866 0.6409 % 188 504 €
Puilaetco Dewaay Private Bankers SA
0.0732 %
68,785 0.0732 % 21 543 €
ING Luxembourg SA (Private Banking)
0.0677 %
63,568 0.0677 % 19 909 €
Rothschild & Co. Asset Management SCS
0.0287 %
26,921 0.0287 % 8 432 €
Lemanik Asset Management SA
0.0122 %
11,464 0.0122 % 3 591 €
UnipolSai Assicurazioni SpA (Investment Portfolio)
0.007923 %
7,441 0.007923 % 2 331 €

Company contact information

Biocartis Group NV

Generaal de Wittelaan 11B

2800, Mechelen

+32 1 563 26 00

http://www.biocartisgroupnv.be
address Biocartis Group NV(BCART)

Sector

Healthcare
Healthcare Services
Healthcare Equipment & Supplies
Medical Equipment, Supplies & Distribution
Medical Equipment

Sales per Business

Sales per region

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.29 EUR
Average target price
1.1 EUR
Spread / Average Target
+279.31%
Consensus

Annual profits - Rate of surprise

Company calendar

Sector Medical Equipment

1st Jan change Capi.
BIOCARTIS GROUP NV Stock Biocartis Group NV
-.--% 29.04M
SHOCKWAVE MEDICAL, INC. Stock Shockwave Medical, Inc.
+72.65% 12.28B
PENUMBRA, INC. Stock Penumbra, Inc.
-19.41% 7.81B
MASIMO CORPORATION Stock Masimo Corporation
+14.98% 7.19B
GETINGE AB Stock Getinge AB
-5.13% 5.23B
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD. Stock Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
+5.78% 4.94B
APT MEDICAL INC. Stock APT Medical Inc.
+17.02% 4.24B
ASAHI INTECC CO., LTD. Stock Asahi Intecc Co., Ltd.
-25.36% 3.97B
INARI MEDICAL, INC. Stock Inari Medical, Inc.
-40.56% 2.24B
SKAN GROUP AG Stock SKAN Group AG
-3.47% 1.92B
Medical Equipment
  1. Stock Market
  2. Equities
  3. BCART Stock
  4. Company Biocartis Group NV